Registration necessary: yes
B cells are an integral part of the adaptive immune system. They are derived from hematopoietic stem cells and mature along the B cell lineage. Intricate signaling pathways control cell fate decisions and maturation of B cells. Disturbance of B cell development at an early progenitor stage gives rise to B cell acute lymphoblastic leukemia, which is the most frequent cancer in childhood.
At this EMBO Workshop, young scientists, clinicians, and leading experts will engage in synergistic discussions about the regulatory mechanisms governing the cell fate decisions of early B cells in health and disease with the aim of promoting basic research in early B cell development. Interdisciplinary networking will allow the development of new perspectives and translation of state-of-the-art basic and clinical science into precision medicine to ultimately improve outcome and quality of life of patients with B cell acute lymphoblastic leukemia.
Registration Deadline: 15 February 2019
Abstract Submission Deadline: 31 January 2019
Chosen Participants Will Be Notified By: 15 February 2019
Payment Deadline: 15 February 2019
Please register and find further information here.